Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Lejeune · SciRah

Researcher profile · Semantic Scholar

M. Lejeune

Share profile

M. Lejeune — researcher profile on SciRah

h-index: 8
Works: 18
Citations: 205

Most-cited papers

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
M. Lejeune, Murat Cem Köse, E. Duray, H. Einsele +2 more
2020Frontiers in Immunology75 citations Open access
Semantic Scholar
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
E. Duray, M. Lejeune, F. Baron, Y. Beguin +7 more
2021Journal of Hematology & Oncology24 citations Open access
Semantic Scholar
The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential tumour gene
A. Bolomsky, J. Muller, K. Stangelberger, M. Lejeune +11 more
2020British Journal of Haematology18 citations Open access
Semantic Scholar
Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease
J. Muller, A. Bolomsky, Sophie Dubois, E. Duray +12 more
2018Haematologica18 citations Open access
Semantic Scholar
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts
J. Muller, E. Duray, M. Lejeune, Sophie Dubois +10 more
2019Cancers17 citations Open access
Semantic Scholar
Nasal sodium cromoglycate (Lomusol) modulates the early phase reaction of mild to moderate persistent allergic rhinitis in patients mono-sensitized to house dust mite: a preliminary study.
M. Lejeune, P. Lefebvre, P. Delvenne, A. El-Shazly
2015International Immunopharmacology14 citations
Semantic Scholar
Radiotheranostic Agents in Hematological Malignancies
J. Caers, E. Duray, L. Vrancken, Guillaume Marcion +9 more
2022Frontiers in Immunology13 citations Open access
Semantic Scholar
Tyrosine kinase inhibition is an important factor for gene expression of CRTH2 in human eosinophils and lymphocytes: A novel mechanism for explaining eosinophils recruitment by the neuro‐immune axis in allergic rhinitis
A. El-Shazly, P. Roncarati, M. Lejeune, Philippe Lefebvre +1 more
2017International Immunopharmacology9 citations
Semantic Scholar
Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma
M. Lejeune, Murat Cem Köse, Mégane Jassin, Marie-jia Gou +9 more
2023HemaSphere7 citations Open access
Semantic Scholar
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
M. Lejeune, E. Duray, M. Peipp, B. Clémenceau +3 more
2021Cancers7 citations Open access
Semantic Scholar
Integrative Analysis of Proteomics and Transcriptomics Reveals the Etrb As Novel Single Target and New Combinatorial Targets for Multiple Myeloma
Murat Cem Köse, M. Lejeune, Marie-jia Gou, E. Duray +6 more
2022Blood1 citations Open access
Semantic Scholar
[What is new in the management of multiple myeloma].
L. Vrancken, J. Muller, M. Lejeune, C. Grégoire +7 more
2018Revue medicale suisse1 citations
Semantic Scholar
Maternal embryonic leucine zipper kinase inhibitor OTSSP 167 has preclinical activity on multiple myeloma bone disease by
J. Muller, A. Bolomsky, Sophie Dubois, E. Duray +14 more
20181 citations
Semantic Scholar
[Multiple myeloma : an overview of advances in biology and treatment].
L. Vrancken, M. Lejeune, M. Pirotte, E. Duray +3 more
2021Revue Medicale de Liege0 citations
Semantic Scholar
OAB-044: Anti-CD38 nanobodies as theranostic agents for multiple myeloma
E. Duray, M. Lejeune, M. Dumoulin, Matthias D'Huyvetter +1 more
2021Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
J. Berg, Bianca Perfler, S. Hatzl, Andreas Reinisch +26 more
2019memo - Magazine of European Medical Oncology0 citations
Semantic Scholar
S122 THE FIRST-IN-CLASS, ORALLY AVAILABLE BMI-1 MODULATORS PTC-028 AND PTC596 DISPLAY POTENT ACTIVITY IN PRE-CLINICAL MODELS OF MULTIPLE MYELOMA
A. Bolomsky, J. Muller, K. Stangelberger, M. Lejeune +11 more
2019HemaSphere0 citations Open access
Semantic Scholar
The first-in-class BMI-1 modulators PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma
A. Bolomsky, J. Muller, M. Lejeune, D. Arnold +7 more
2019Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Caers×16
Invite
J. Caers — researcher profile on SciRah
E. Duray×15
Invite
E. Duray — researcher profile on SciRah
Y. Beguin×10
Invite
Y. Beguin — researcher profile on SciRah
J. Muller×8
Invite
J. Muller — researcher profile on SciRah

×6

Invite

A. Bolomsky — researcher profile on SciRah

Invite

L. Vrancken — researcher profile on SciRah

Invite

H. Ludwig — researcher profile on SciRah

Invite

F. Baron — researcher profile on SciRah

Invite

H. Breid — researcher profile on SciRah

Invite

N. Zojer — researcher profile on SciRah

Sophie Dubois×4

Invite

Sophie Dubois — researcher profile on SciRah

Murat Cem Köse×3

Invite

Murat Cem Köse — researcher profile on SciRah